Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06750653 · ClinicalTrials.gov registry record · Phase 4
Skin Barrier Function and Inflammation in Aging: The BIA Study
A Phase 4 study of Aging and Inflammation, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06750653 is a Phase 4 study of Aging and Inflammation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 32 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06750653, a Phase 4 study of Aging and Inflammation, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.
Conditions Studied
Interventions
- OTHER CeraVe Moisturizing Cream
- DRUG Vaseline
Study Locations (1)
California
- UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2026-04-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06750653
The ClinicalTrials.gov registry entry for NCT06750653 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which CeraVe Moisturizing Cream is the first listed.
NCT06750653 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06750653 about?
NCT06750653 is a clinical study titled "Skin Barrier Function and Inflammation in Aging: The BIA Study". This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with...
What is the current status of trial NCT06750653?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2025-02-06. Estimated completion is 2026-04-15.
What conditions does trial NCT06750653 study?
This clinical trial studies the following conditions: Aging, Inflammation, Skin Inflammation.
What interventions are being tested in trial NCT06750653?
The interventions under investigation include: CeraVe Moisturizing Cream (OTHER), Vaseline (DRUG).
Who is sponsoring clinical trial NCT06750653?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06750653 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
RECRUITING · Phase 4
-
Role of Menopause in Thermoregulation
RECRUITING · Phase 4
-
Aging, Beta Blockers, and Thermoregulatory Responses
RECRUITING · Phase 4
-
The Effect of NAD Supplementation on Brain Vascular Health in Aging
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.